Lung cancer occurs when abnormal cells in the lungs undergo uncontrolled growth and form a tumour. As the tumour grows, it can interfere with the normal functioning of the lungs, impacting the ability to breathe and leading to various symptoms.
Targeted therapy for lung cancer is primarily used in cases where specific genetic mutations or molecular changes are identified in the cancer cells. The targeted therapy drugs are designed to inhibit the growth and spread of cancer cells by targeting these specific genetic abnormalities. The treatment procedure involves the administration of oral medications that specifically target and block the action of the mutated genes or proteins.
Recovery time depends on the response to treatment and the management of side effects. Regular monitoring and follow-up appointments with the oncologists are crucial in assessing the effectiveness of the targeted therapy and adjusting the treatment plan if needed.
Mr. Punna Krishnaiah from Rangareddy successfully received Targeted Therapy for Lung Cancer at Yashoda Hospitals, Hyderabad, under the supervision of Dr. G. Vamshi Krishna Reddy, Director-Oncology Services, Consultant Medical Oncologist & Hemato Oncologist.